Log in

Bayer Stock Price, News & Analysis (FRA:BAYN)

€66.64
+1.03 (+1.57 %)
(As of 10/16/2019 02:50 AM ET)
Today's Range
€65.72
Now: €66.64
€67.22
50-Day Range
€60.62
MA: €65.83
€69.07
52-Week Range
€91.58
Now: €66.64
€123.82
Volume3.52 million shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents. Read More…

Industry, Sector and Symbol

Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+49-214-301

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees111,015
Next Earnings DateN/A
OptionableNot Optionable

Receive BAYN News and Ratings via Email

Sign-up to receive the latest news and ratings for BAYN and its competitors with MarketBeat's FREE daily newsletter.


Bayer (FRA:BAYN) Frequently Asked Questions

What is Bayer's stock symbol?

Bayer trades on the FRA under the ticker symbol "BAYN."

What price target have analysts set for BAYN?

22 analysts have issued 12 month target prices for Bayer's stock. Their forecasts range from €61.00 to €123.00. On average, they anticipate Bayer's share price to reach €79.90 in the next year. This suggests a possible upside of 19.9% from the stock's current price. View Analyst Price Targets for Bayer.

What is the consensus analysts' recommendation for Bayer?

22 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bayer in the last year. There are currently 1 sell rating, 10 hold ratings and 11 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Bayer.

Has Bayer been receiving favorable news coverage?

News coverage about BAYN stock has been trending very negative on Wednesday, InfoTrie Sentiment reports. InfoTrie ranks the sentiment of media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Bayer earned a media sentiment score of -3.3 on InfoTrie's scale. They also assigned press coverage about the healthcare company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock's share price in the near term. View News Stories for Bayer.

Who are some of Bayer's key competitors?

What other stocks do shareholders of Bayer own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bayer investors own include Hawkins (HWKN), CA (CA), Bayer (BAYRY), BlackRock (BLK), Endologix (ELGX), Basf (BAS), Bayerische Motoren Werke (BMW), The Coca-Cola (KO), General Electric (GE) and ESSILOR INTL S/S (ESLOY).

Who are Bayer's key executives?

Bayer's management team includes the folowing people:
  • Mr. Werner Baumann, Chairman of Management & CEO (Age 57)
  • Mr. Wolfgang U. Nickl, CFO & Member of Management Board (Age 50)
  • Mr. Liam Condon, Pres of Bayer Crop Science Division & Member of Management Board (Age 51)
  • Dr. Kemal Malik, Head of Innovation & Member of Management Board (Age 57)
  • Dr. Hartmut Klusik, Head of HR, Technology & Sustainability, Labor Director and Member of Management Board (Age 63)

What is Bayer's stock price today?

One share of BAYN stock can currently be purchased for approximately €66.64.

What is Bayer's official website?

The official website for Bayer is http://www.bayer.de/.

How can I contact Bayer?

Bayer's mailing address is Kaiser-Wilhelm-Allee 1, LEVERKUSEN, 51373, Germany. The healthcare company can be reached via phone at +49-214-301.


MarketBeat Community Rating for Bayer (FRA BAYN)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  1,434 (Vote Outperform)
Underperform Votes:  937 (Vote Underperform)
Total Votes:  2,371
MarketBeat's community ratings are surveys of what our community members think about Bayer and other stocks. Vote "Outperform" if you believe BAYN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BAYN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/16/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel